Notable Electronic Health Record Milestones
National Library of Medicine makes Medical Literature Analysis and Retrieval System (MEDLARS) operational. Image courtesy of the National Library of Medicine.
Regenstrief Institute develops first EHR System with inpatient/outpatient information. Director Clement McDonald (front) worked on developing the computer-based order entry system. Image courtesy of Indiana University School of Medicine.
Veterans Adminsitrations starts work on VistA, the Veterans Health Information Systems and Technology Architecture. Image courtesy of the Department of Veterans Affairs.
Congress endorses public use of VistA.
The Health Insurance Portability and Accountability Act is passed with major implicates to EHR use, disclosure and confidentiality.
President George W. Bush promotes adoption of EHRs. Image courtesy of WhiteHouse.gov.
The Health Information Technology for Economic and Clinical Health (HITECH) Act passes, encouraging EHR adoption
Since 2008, electronic health record adoption has increased 41% -- an rise attributable to a mandate from the U.S. government and paid incentives to doctors' offices and health care provider networks to make investments in the technology.
Although there's still a long road ahead in terms of achieving meaningful use incentives, this slideshow explores the history of EHR devices.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Study Zeroes in on Cause of Castration-Resistant Prostate Cancer
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC